Alexandria Real Equities, a life sciences real estate developer, has bought a 5.2-acre property in Bellevue, Wash., for $77.5 million. The purchase was first reported by the Puget Sound Business… Read More
Joel Marcus’ fortunes have risen with those of the life sciences industry. The executive chairman of life sciences builder Alexandria Real Estate Equities first bought laboratory space in Seattle in… Read More
More than 500 units of affordable housing, a community center, a performing arts theater, a festival street for farmers markets, an elementary school. These were linchpins of proposals from a… Read More
As it closes in on one of the most valuable land deals in Seattle history, Alexandria Real Estate Equities is betting that biotech can thrive in a real estate market… Read More
One of the last big chunks of land in the booming Seattle neighborhood of South Lake Union will turn into a life sciences hub — with proceeds of the sale… Read More
Adaptive Biotechnologies is charting a massive expansion of its Seattle headquarters following the completion of a recent initial public offering. The company signed a 100,000 square-foot lease, tripling its current… Read More